Impact of diabetes on medical costs in the pre- and postoperative year of lower extremity amputations in Belgium
Authors' conclusion
LEA-related medical costs were high. Diabetes significantly impacted costs, but differences in costs diminished with higher amputation levels. Individuals with multiple amputations generated the highest costs.
Study context
- Population
- Belgian citizens undergoing lower extremity amputation (LEAs) in 2014; 2130 had diabetes3,324 with LEA
- Participants
- 1,029 / 2,295 / 31,716
- Exposure
- Individuals undergoing minor or major LEA vs matched amputation-free individuals
- Major LEAn = 1,029
- Minor LEAn = 2,295
- No LEAn = 31,716reference
- Outcome
- Median medical costs per capita in euros
- Follow-up
- 12 months preceding and following LEA
Methodological detailsmatched amputation-free comparison group
- Matched amputation-free comparison group
Main finding
As reported in the abstract
Median medical costs per capita, individuals with diabetes · year preceding amputation
Major LEA
€49,735
median
Minor LEA
€24,243
median
No LEA
€2,877
median
Observational data: associations, not effects.
Further findings
Median €
| Outcome | Major LEA | Minor LEA | No LEA |
|---|---|---|---|
| Median medical costs per capita, individuals with diabetes · post-amputation year | 45,740 | 21,445 | 2,284 |
Costs with multiple LEAs, individuals with diabetes
- LEAs preceded index amputation
- €39,313-€89,563
- LEAs followed index amputation
- €46,629-€92,877
Costs in individuals dying in the year after a major LEA
- Remarkably lower costs
Original publication
Impact of diabetes on medical costs in the pre- and postoperative year of lower extremity amputations in Belgium. Diabetes Res Clin Pract. Published 23 December 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →